Clinical Trial: Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Respiratory Syncytial Virus Infection
Study Type: INTERVENTIONAL
Official Title: A Phase IIb, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an RSV Vaccine Candidate in Adult Participants 60 Years and Older
Brief Summary:
The purpose of this Phase IIb study is to evaluate the efficacy of the RSV vaccine candidate for the prevention of lower respiratory tract disease (LRTD) due to RSV.The study will enroll approximately 4500 adults aged 60 years and older in a 1:1 ratio to receive a single intra-muscular (IM) administration of either a pre-determined dose of the RSV vaccine candidate or placebo.
Read more